NEW! Essilor® Stellest® lenses are clinically proven to slow myopia progression in children* 1
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children* 1

By clicking “Sign up”, I confirm that I am over 18 years old and I agree that my personal data can be used by Luxottica of America, Inc. to send me news, special offers, and other marketing communications. For further information, see our Privacy Policy, and Terms & Conditions.
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children* 1
Choose your location
Select how many patients
Schedule an eye exam
Add to calendar
1. Essilor International, data on file (2025)
* Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
† H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.
‡Aesthetic finish